Biological functions of casein kinase 1 isoforms and putative roles in tumorigenesis (original) (raw)

References

  1. Knippschild U, Gocht A, Wolff S, Huber N, Löhler J, Stöter M: The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal. 2005, 17: 675-689. 10.1016/j.cellsig.2004.12.011
    Article CAS PubMed Google Scholar
  2. Knippschild U, Wolff S, Giamas G, Brockschmidt C, Wittau M, Wörl PU, Eismann T, Stöter M, Würl PU, Stöter M: The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development. Onkologie. 2005, 28: 508-514. 10.1159/000087137
    Article CAS PubMed Google Scholar
  3. Gross SD, Anderson RA: Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cell Signal. 1998, 10: 699-711. 10.1016/S0898-6568(98)00042-4
    Article CAS PubMed Google Scholar
  4. Price MA: CKI, there’s more than one: casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev. 2006, 20: 399-410. 10.1101/gad.1394306
    Article CAS PubMed Google Scholar
  5. Cheong JK, Virshup DM: Casein kinase 1: Complexity in the family. Int J Biochem Cell Biol. 2011, 43: 465-469. 10.1016/j.biocel.2010.12.004
    Article CAS PubMed Google Scholar
  6. Fish KJ, Cegielska A, Getman ME, Landes GM, Virshup DM: Isolation and characterization of human casein kinase I epsilon (CKI), a novel member of the CKI gene family. J Biol Chem. 1995, 270: 14875-14883. 10.1074/jbc.270.25.14875
    Article CAS PubMed Google Scholar
  7. Greer YE, Rubin JS: Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth. J Cell Biol. 2011, 192: 993-1004. 10.1083/jcb.201011111
    Article PubMed Central CAS PubMed Google Scholar
  8. Carvalho G, Le Guelte A, Demian C, Vazquez A, Gavard J, Bidère N: Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation. J Cell Sci. 2010, 123 (Pt 14): 2375-2380.
    Article CAS PubMed Google Scholar
  9. Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A, Journot L, Antonsson B, Martinou JC: Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell. 2001, 8: 601-611. 10.1016/S1097-2765(01)00335-5
    Article CAS PubMed Google Scholar
  10. Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE, Thorburn A, Kidd VJ, Slaughter CA, Osborn SL, Winoto A, Tang W-J, Peter ME: Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell. 2005, 19: 321-332. 10.1016/j.molcel.2005.06.024
    Article CAS PubMed Google Scholar
  11. Huart A-S, MacLaine NJ, Meek DW, Hupp TR: CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability. J Biol Chem. 2009, 284: 32384-32394. 10.1074/jbc.M109.052647
    Article PubMed Central CAS PubMed Google Scholar
  12. Bischof J, Randoll S-J, Süßner N, Henne-Bruns D, Pinna LA, Knippschild U: CK1δ kinase activity is modulated by Chk1-mediated phosphorylation. PLoS One. 2013, 8: e68803- 10.1371/journal.pone.0068803
    Article PubMed Central CAS PubMed Google Scholar
  13. Cruciat C-M, Dolde C, de Groot REA, Ohkawara B, Reinhard C, Korswagen HC, Niehrs C: RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling. Science. 2013, 339: 1436-1441. doi:10.1038/onc.2013.564,
    Article CAS PubMed Google Scholar
  14. Yim DGR, Ghosh S, Guy GR, Virshup DM: Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling. Oncogene. 2014,
    Google Scholar
  15. Price MA, Kalderon D: Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell. 2002, 108: 823-835. 10.1016/S0092-8674(02)00664-5
    Article CAS PubMed Google Scholar
  16. Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, Rauh-Hain JA, Ng S-K, Choi P-W, Fong W-P, Agar NYR, Welch WR, Berkowitz RS, Ng S-W: Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med. 2012, 4: 952-963. 10.1002/emmm.201101094
    Article PubMed Central CAS PubMed Google Scholar
  17. Xu F, Wang Y-L, Chang J-J, Du S-C, Diao L, Jiang N, Wang H-J, Ma D, Zhang J: Mammalian sterile 20-like kinase 1/2 inhibits the Wnt/β-catenin signalling pathway by directly binding casein kinase 1ϵ. Biochem J. 2014, 458: 159-169. 10.1042/BJ20130986
    Article CAS PubMed Google Scholar
  18. Bidère N, Ngo VN, Lee J, Collins C, Zheng L, Wan F, Davis RE, Lenz G, Anderson DE, Arnoult D, Vazquez A, Sakai K, Zhang J, Meng Z, Veenstra TD, Staudt LM, Lenardo MJ: Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009, 458: 92-96. 10.1038/nature07613
    Article PubMed Central PubMed CAS Google Scholar
  19. Wang Y, Hu L, Tong X, Ye X: Casein kinase 1γ1 inhibits the RIG-I/TLR signaling pathway through phosphorylating p65 and promoting its degradation. J Immunol. 2014, 192: 1855-1861. 10.4049/jimmunol.1302552
    Article CAS PubMed Google Scholar
  20. Wu S, Chen L, Becker A, Schonbrunn E, Chen J: Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding. Mol Cell Biol. 2012, 32: 4821-4832. 10.1128/MCB.00851-12
    Article PubMed Central CAS PubMed Google Scholar
  21. Milne DM, Palmer RH, Campbell DG, Meek DW: Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene. 1992, 7: 1361-1369.
    CAS PubMed Google Scholar
  22. Rena G, Bain J, Elliott M, Cohen P: D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 2004, 5: 60-65. 10.1038/sj.embor.7400048
    Article PubMed Central CAS PubMed Google Scholar
  23. Magliozzi R, Low TY, Weijts BGMW, Cheng T, Spanjaard E, Mohammed S, van Veen A, Ovaa H, de Rooij J, Zwartkruis FJT, Bos JL, de Bruin A, Heck AJR, Guardavaccaro D: Control of epithelial cell migration and invasion by the IKKβ- and CK1α-mediated degradation of RAPGEF2. Dev Cell. 2013, 27: 574-585. 10.1016/j.devcel.2013.10.023
    Article CAS PubMed Google Scholar
  24. Waddell DS, Liberati NT, Guo X, Frederick JP, Wang X-F: Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway. J Biol Chem. 2004, 279: 29236-29246. 10.1074/jbc.M400880200
    Article CAS PubMed Google Scholar
  25. Rubinfeld B, Tice DA, Polakis P: Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon. J Biol Chem. 2001, 276: 39037-39045. 10.1074/jbc.M105148200
    Article CAS PubMed Google Scholar
  26. Shen T, Liu Y, Cseresnyés Z, Hawkins A, Randall WR, Schneider MF: Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell. 2006, 17: 1570-1582. 10.1091/mbc.E05-08-0780
    Article PubMed Central CAS PubMed Google Scholar
  27. Klein TJ, Jenny A, Djiane A, Mlodzik M: CKIepsilon/discs overgrown promotes both Wnt-Fz/beta-catenin and Fz/PCP signaling in Drosophila. Curr Biol. 2006, 16: 1337-1343. 10.1016/j.cub.2006.06.030
    Article CAS PubMed Google Scholar
  28. Venerando A, Girardi C, Ruzzene M, Pinna LA: Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation. Biochem J. 2013, 452: 131-137.
    Article CAS PubMed Google Scholar
  29. Del Valle-Pérez B, Arqués O, Vinyoles M, de Herreros AG, Duñach M: Coordinated action of CK1 isoforms in canonical Wnt signaling. Mol Cell Biol. 2011, 31: 2877-2888. 10.1128/MCB.01466-10
    Article PubMed Central PubMed CAS Google Scholar
  30. Flotow H, Graves PR, Wang AQ, Fiol CJ, Roeske RW, Roach PJ: Phosphate groups as substrate determinants for casein kinase I action. J Biol Chem. 1990, 265: 14264-14269.
    CAS PubMed Google Scholar
  31. McKenzie JAG, Riento K, Ridley AJ: Casein kinase I epsilon associates with and phosphorylates the tight junction protein occludin. FEBS Lett. 2006, 580: 2388-2394. 10.1016/j.febslet.2006.03.048
    Article CAS PubMed Google Scholar
  32. Sillibourne JE, Milne DM, Takahashi M, Ono Y, Meek DW: Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450. J Mol Biol. 2002, 322: 785-797. 10.1016/S0022-2836(02)00857-4
    Article CAS PubMed Google Scholar
  33. Wolff S, Stöter M, Giamas G, Piesche M, Henne-Bruns D, Banting G, Knippschild U: Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. FEBS Lett. 2006, 580: 6477-6484. 10.1016/j.febslet.2006.10.068
    Article CAS PubMed Google Scholar
  34. Wolff S, Xiao Z, Wittau M, Süssner N, Stöter M, Knippschild U: Interaction of casein kinase 1 delta (CK1 delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A). Biochim Biophys Acta. 2005, 1745: 196-206. 10.1016/j.bbamcr.2005.05.004
    Article CAS PubMed Google Scholar
  35. Behrend L, Stöter M, Kurth M, Rutter G, Heukeshoven J, Deppert W, Knippschild U: Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures, microtubules and the spindle apparatus. Eur J Cell Biol. 2000, 79: 240-251. 10.1078/S0171-9335(04)70027-8
    Article CAS PubMed Google Scholar
  36. Yin H, Laguna KA, Li G, Kuret J: Dysbindin structural homologue CK1BP is an isoform-selective binding partner of human casein kinase-1. Biochemistry. 2006, 45: 5297-5308. 10.1021/bi052354e
    Article CAS PubMed Google Scholar
  37. Zemp I, Wandrey F, Rao S, Ashiono C, Wyler E, Montellese C, Kutay U: CK1δ and CK1ϵ are components of human 40S subunit precursors required for cytoplasmic 40S maturation. J Cell Sci. 2014, 127 (Pt 6): 1242-1253.
    Article CAS PubMed Google Scholar
  38. Brockman JL, Gross SD, Sussman MR, Anderson RA: Cell cycle-dependent localization of casein kinase I to mitotic spindles. Proc Natl Acad Sci U S A. 1992, 89: 9454-9458. 10.1073/pnas.89.20.9454
    Article PubMed Central CAS PubMed Google Scholar
  39. Gross SD, Simerly C, Schatten G, Anderson RA: A casein kinase I isoform is required for proper cell cycle progression in the fertilized mouse oocyte. J Cell Sci. 1997, 110 (Pt 2): 3083-3090.
    CAS PubMed Google Scholar
  40. Wang L, Lu A, Zhou H-X, Sun R, Zhao J, Zhou C-J, Shen J-P, Wu S-N, Liang C-G: Casein kinase 1 alpha regulates chromosome congression and separation during mouse oocyte meiotic maturation and early embryo development. PLoS One. 2013, 8: e63173- 10.1371/journal.pone.0063173
    Article PubMed Central CAS PubMed Google Scholar
  41. Duan S, Skaar JR, Kuchay S, Toschi A, Kanarek N, Ben-Neriah Y, Pagano M: mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR. Mol Cell. 2011, 44: 317-324. 10.1016/j.molcel.2011.09.005
    Article PubMed Central CAS PubMed Google Scholar
  42. Izeradjene K, Douglas L, Delaney AB, Houghton JA: Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Cancer Res. 2004, 64: 8036-8044. 10.1158/0008-5472.CAN-04-0762
    Article CAS PubMed Google Scholar
  43. Zhao Y, Qin S, Atangan LI, Molina Y, Okawa Y, Arpawong HT, Ghosn C, Xiao J-H, Vuligonda V, Brown G, Chandraratna RAS: Casein kinase 1alpha interacts with retinoid X receptor and interferes with agonist-induced apoptosis. J Biol Chem. 2004, 279: 30844-30849. 10.1074/jbc.M404651200
    Article CAS PubMed Google Scholar
  44. Sinnberg T, Menzel M, Kaesler S, Biedermann T, Sauer B, Nahnsen S, Schwarz M, Garbe C, Schittek B: Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis. Cancer Res. 2010, 70: 6999-7009. 10.1158/0008-5472.CAN-10-0645
    Article CAS PubMed Google Scholar
  45. Tobin AB: Are we beta-ARKing up the wrong tree? Casein kinase 1 alpha provides an additional pathway for GPCR phosphorylation. Trends Pharmacol Sci. 2002, 23: 337-343. 10.1016/S0165-6147(02)02043-6
    Article CAS PubMed Google Scholar
  46. Waugh MG, Challiss RA, Berstein G, Nahorski SR, Tobin AB: Agonist-induced desensitization and phosphorylation of m1-muscarinic receptors. Biochem J. 1999, 338 (Pt 1): 175-183.
    Article PubMed Central CAS PubMed Google Scholar
  47. Okamura H, Garcia-Rodriguez C, Martinson H, Qin J, Virshup DM, Rao A: A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol Cell Biol. 2004, 24: 4184-4195. 10.1128/MCB.24.10.4184-4195.2004
    Article PubMed Central CAS PubMed Google Scholar
  48. Dejmek J, Säfholm A, Kamp Nielsen C, Andersson T, Leandersson K: Wnt-5a/Ca2 + −induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells. Mol Cell Biol. 2006, 26: 6024-6036. 10.1128/MCB.02354-05
    Article PubMed Central CAS PubMed Google Scholar
  49. Vielhaber E, Eide E, Rivers A, Gao ZH, Virshup DM: Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I epsilon. Mol Cell Biol. 2000, 20: 4888-4899. 10.1128/MCB.20.13.4888-4899.2000
    Article PubMed Central CAS PubMed Google Scholar
  50. Hirota T, Lee JW, Lewis WG, Zhang EE, Breton G, Liu X, Garcia M, Peters EC, Etchegaray J-P, Traver D, Schultz PG, Kay SA: High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinase. PLoS Biol. 2010, 8: e1000559- 10.1371/journal.pbio.1000559
    Article PubMed Central CAS PubMed Google Scholar
  51. Walton KM, Fisher K, Rubitski D, Marconi M, Meng Q-J, Sládek M, Adams J, Bass M, Chandrasekaran R, Butler T, Griffor M, Rajamohan F, Serpa M, Chen Y, Claffey M, Hastings M, Loudon A, Maywood E, Ohren J, Doran A, Wager TT: Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J Pharmacol Exp Ther. 2009, 330: 430-439. 10.1124/jpet.109.151415
    Article CAS PubMed Google Scholar
  52. Harms E, Young MW, Saez L: CK1 and GSK3 in the Drosophila and mammalian circadian clock. Novartis Found Symp. 2003, 253 (102–9): 277-284. discussion,
    Google Scholar
  53. Meng Q-J, Maywood ES, Bechtold DA, Lu W-Q, Li J, Gibbs JE, Dupré SM, Chesham JE, Rajamohan F, Knafels J, Sneed B, Zawadzke LE, Ohren JF, Walton KM, Wager TT, Hastings MH, Loudon ASI: Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc Natl Acad Sci U S A. 2010, 107: 15240-15245. 10.1073/pnas.1005101107
    Article PubMed Central CAS PubMed Google Scholar
  54. Behrend L, Milne DM, Stöter M, Deppert W, Campbell LE, Meek DW, Knippschild U: IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene. 2000, 19: 5303-5313. 10.1038/sj.onc.1203939
    Article CAS PubMed Google Scholar
  55. Stöter M, Bamberger AM, Aslan B, Kurth M, Speidel D, Löning T, Frank HG, Kaufmann P, Löhler J, HenneBruns D, Deppert W, Knippschild U:Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells. Oncogene. 2005, 24: 7964-7975. 10.1038/sj.onc.1208941
    Article PubMed CAS Google Scholar
  56. Greer YE, Westlake CJ, Gao B, Bharti K, Shiba Y, Xavier CP, Pazour GJ, Yang Y, Rubin JS: Casein kinase 1δ functions at the centrosome and Golgi to promote ciliogenesis. Mol Biol Cell. 2014, 25: 1629-1640. 10.1091/mbc.E13-10-0598
    Article PubMed Central CAS PubMed Google Scholar
  57. Hanger DP, Byers HL, Wray S, Leung K-Y, Saxton MJ, Seereeram A, Reynolds CH, Ward MA, Anderton BH: Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem. 2007, 282: 23645-23654. 10.1074/jbc.M703269200
    Article CAS PubMed Google Scholar
  58. León-Espinosa G, García E, García-Escudero V, Hernández F, Defelipe J, Avila J: Changes in tau phosphorylation in hibernating rodents. J Neurosci Res. 2013, 91: 954-962. 10.1002/jnr.23220
    Article PubMed CAS Google Scholar
  59. Li G, Yin H, Kuret J: Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J Biol Chem. 2004, 279: 15938-15945. 10.1074/jbc.M314116200
    Article CAS PubMed Google Scholar
  60. Johnson AE, Chen J-S, Gould KL: CK1 is required for a mitotic checkpoint that delays cytokinesis. Curr Biol. 2013, 23: 1920-1926. 10.1016/j.cub.2013.07.077
    Article PubMed Central CAS PubMed Google Scholar
  61. Huart A-S, Saxty B, Merritt A, Nekulova M, Lewis S, Huang Y, Vojtesek B, Kettleborough C, Hupp TR: A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway. Bioorg Med Chem Lett. 2013, 23: 5578-5585. 10.1016/j.bmcl.2013.08.046
    Article CAS PubMed Google Scholar
  62. Bernatik O, Ganji RS, Dijksterhuis JP, Konik P, Cervenka I, Polonio T, Krejci P, Schulte G, Bryja V: Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases. J Biol Chem. 2011, 286: 10396-10410. 10.1074/jbc.M110.169870
    Article PubMed Central CAS PubMed Google Scholar
  63. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002, 108: 837-847. 10.1016/S0092-8674(02)00685-2
    Article CAS PubMed Google Scholar
  64. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I: Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002, 16: 1066-1076. 10.1101/gad.230302
    Article PubMed Central CAS PubMed Google Scholar
  65. Carreras Puigvert J, Von Stechow L, Siddappa R, Pines A, Bahjat M, Haazen LCJM, Olsen JV, Vrieling H, Meerman JHN, Mullenders LHF, Van De Water B, Danen EHJ: Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells. Sci Signal. 2013, 6: ra5-
    Article PubMed CAS Google Scholar
  66. Ha N-C, Tonozuka T, Stamos JL, Choi H-J, Weis WI: Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell. 2004, 15: 511-521. 10.1016/j.molcel.2004.08.010
    Article CAS PubMed Google Scholar
  67. Hämmerlein A, Weiske J, Huber O: A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Cell Mol Life Sci. 2005, 62: 606-618. 10.1007/s00018-005-4507-7
    Article PubMed CAS Google Scholar
  68. Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, Hoekstra MF, Meek DW: p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene. 1997, 15: 1727-1736. 10.1038/sj.onc.1201541
    Article CAS PubMed Google Scholar
  69. Dumaz N, Milne DM, Meek DW: Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett. 1999, 463: 312-316. 10.1016/S0014-5793(99)01647-6
    Article CAS PubMed Google Scholar
  70. Winter M, Milne D, Dias S, Kulikov R, Knippschild U, Blattner C, Meek D: Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry. 2004, 43: 16356-16364. 10.1021/bi0489255
    Article CAS PubMed Google Scholar
  71. Elyada E, Pribluda A, Goldstein RE, Morgenstern Y, Brachya G, Cojocaru G, Snir-Alkalay I, Burstain I, Haffner-Krausz R, Jung S, Wiener Z, Alitalo K, Oren M, Pikarsky E, Ben-Neriah Y: CKIα ablation highlights a critical role for p53 in invasiveness control. Nature. 2011, 470: 409-413. 10.1038/nature09673
    Article CAS PubMed Google Scholar
  72. Sarasqueta AF, Forte G, Corver WE, de Miranda NF, Ruano D, van Eijk R, Oosting J, Tollenaar RAEM, van Wezel T, Morreau H: Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer. BMC Cancer. 2013, 13: 277- 10.1186/1471-2407-13-277
    Article CAS PubMed Google Scholar
  73. Järås M, Miller PG, Chu LP, Puram RV, Fink EC, Schneider RK, Al-Shahrour F, Peña P, Breyfogle LJ, Hartwell KA, McConkey ME, Cowley GS, Root DE, Kharas MG, Mullally A, Ebert BL: Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. J Exp Med. 2014, 211: 605-612. 10.1084/jem.20131033
    Article PubMed Central PubMed Google Scholar
  74. Chen L, Li C, Pan Y, Chen J: Regulation of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol. 2005, 25: 6509-6520. 10.1128/MCB.25.15.6509-6520.2005
    Article PubMed Central CAS PubMed Google Scholar
  75. Venerando A, Marin O, Cozza G, Bustos VH, Sarno S, Pinna LA: Isoform specific phosphorylation of p53 by protein kinase CK1. Cell Mol Life Sci. 2010, 67: 1105-1118. 10.1007/s00018-009-0236-7
    Article CAS PubMed Google Scholar
  76. Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, Shaik S, Wan L, Ang XL, Mock C, Yin H, Stommel JM, Gygi S, Lahav G, Asara J, Xiao Z-XJ, Kaelin WG, Harper JW, Wei W: Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell. 2010, 18: 147-159. 10.1016/j.ccr.2010.06.015
    Article PubMed Central CAS PubMed Google Scholar
  77. Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D: MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res. 2012, 72: 1751-1762. 10.1158/0008-5472.CAN-11-3027
    Article PubMed Central CAS PubMed Google Scholar
  78. Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM: Posttranslational mechanisms regulate the mammalian circadian clock. Cell. 2001, 107: 855-867. 10.1016/S0092-8674(01)00610-9
    Article CAS PubMed Google Scholar
  79. Yong TJ, Gan YY, Toh BH, Sentry JW: Human CKIalpha(L) and CKIalpha(S) are encoded by both 2.4- and 4. 2-kb transcripts, the longer containing multiple RNA-destablising elements. Biochim Biophys Acta. 2000, 1492: 425-433. 10.1016/S0167-4781(00)00146-9
    Article CAS PubMed Google Scholar
  80. Green CL, Bennett GS: Identification of four alternatively spliced isoforms of chicken casein kinase I alpha that are all expressed in diverse cell types. Gene. 1998, 216: 189-195. 10.1016/S0378-1119(98)00291-1
    Article CAS PubMed Google Scholar
  81. Fu Z, Green CL, Bennett GS: Relationship between casein kinase I isoforms and a neurofilament-associated kinase. J Neurochem. 1999, 73: 830-838.
    Article CAS PubMed Google Scholar
  82. Budini M, Jacob G, Jedlicki A, Pérez C, Allende CC, Allende JE: Autophosphorylation of carboxy-terminal residues inhibits the activity of protein kinase CK1alpha. J Cell Biochem. 2009, 106: 399-408. 10.1002/jcb.22019
    Article CAS PubMed Google Scholar
  83. Cegielska A, Gietzen KF, Rivers A, Virshup DM: Autoinhibition of casein kinase I epsilon (CKI epsilon) is relieved by protein phosphatases and limited proteolysis. J Biol Chem. 1998, 273: 1357-1364. 10.1074/jbc.273.3.1357
    Article CAS PubMed Google Scholar
  84. Graves PR, Roach PJ: Role of COOH-terminal phosphorylation in the regulation of casein kinase I delta. J Biol Chem. 1995, 270: 21689-21694. 10.1074/jbc.270.37.21689
    Article CAS PubMed Google Scholar
  85. Longenecker KL, Roach PJ, Hurley TD: Crystallographic studies of casein kinase I delta toward a structural understanding of auto-inhibition. Acta Crystallogr D Biol Crystallogr. 1998, 54 (Pt 3): 473-475.
    Article CAS PubMed Google Scholar
  86. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterson AG, Kim K, Melancon B, Ghidu VP, Sulikowski GA, LaFleur B, Salic A, Lee LA, Miller DM, Lee E, Miller DM: Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. Nat Chem Biol. 2010, 6: 829-836. 10.1038/nchembio.453
    Article PubMed Central CAS PubMed Google Scholar
  87. Maritzen T, Lohler J, Deppert W, Knippschild U: Casein kinase I delta (CKIdelta) is involved in lymphocyte physiology. Eur J Cell Biol. 2003, 82: 369-378. 10.1078/0171-9335-00323
    Article CAS PubMed Google Scholar
  88. Masuda K, Ono M, Okamoto M, Morikawa W, Otsubo M, Migita T, Tsuneyoshi M, Okuda H, Shuin T, Naito S, Kuwano M: Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. Int J Cancer. 2003, 105: 803-810. 10.1002/ijc.11152
    Article CAS PubMed Google Scholar
  89. Brockschmidt C, Hirner H, Huber N, Eismann T, Hillenbrand A, Giamas G, Radunsky B, Ammerpohl O, Bohm B, Henne-Bruns D, Kalthoff H, Leithäuser F, Trauzold A, Knippschild U, Leithäuser F: Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut. 2008, 57: 799-806. 10.1136/gut.2007.123695
    Article CAS PubMed Google Scholar
  90. Knippschild U, Krüger M, Richter J, Xu P, García-Reyes B, Peifer C, Halekotte J, Bakulev V, Bischof J: The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis. Front Oncol. 2014, 4: 96-
    Article PubMed Central PubMed Google Scholar
  91. Sun D, Zhou M, Kowolik CM, Trisal V, Huang Q, Kernstine KH, Lian F, Shen B: Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma. Melanoma Res. 2011, 21: 335-343. 10.1097/CMR.0b013e328346b715
    Article PubMed Central CAS PubMed Google Scholar
  92. Fuja TJ, Lin F, Osann KE, Bryant PJ: Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma. Cancer Res. 2004, 64: 942-951. 10.1158/0008-5472.CAN-03-2100
    Article CAS PubMed Google Scholar
  93. Tsai I-C, Woolf M, Neklason DW, Branford WW, Yost HJ, Burt RW, Virshup DM: Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism. Int J Cancer. 2007, 120: 1005-1012.
    Article CAS PubMed Google Scholar
  94. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N: ntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013, 6: pl1-
    Article PubMed Central PubMed CAS Google Scholar
  95. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2: 401-404. 10.1158/2159-8290.CD-12-0095
    Article PubMed Google Scholar
  96. Antonov AV, Krestyaninova M, Knight RA, Rodchenkov I, Melino G, Barlev NA: PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome. Oncogene. 2014, 33: 1621-1628. 10.1038/onc.2013.119
    Article CAS PubMed Google Scholar
  97. Kim SY, Dunn IF, Firestein R, Gupta P, Wardwell L, Repich K, Schinzel AC, Wittner B, Silver SJ, Root DE, Boehm JS, Ramaswamy S, Lander ES, Hahn WC: CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS One. 2010, 5: e8979- 10.1371/journal.pone.0008979
    Article PubMed Central PubMed CAS Google Scholar
  98. Lin S-H, Lin Y-M, Yeh C-M, Chen C-J, Chen M-W, Hung H-F, Yeh K-T, Yang S-F: Casein kinase 1 epsilon expression predicts poorer prognosis in low T-stage oral cancer patients. Int J Mol Sci. 2014, 15: 2876-2891. 10.3390/ijms15022876
    Article PubMed Central PubMed CAS Google Scholar
  99. Cheong JK, Nguyen TH, Wang H, Tan P, Voorhoeve PM, Lee SH, Virshup DM: IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ε and Wnt/β-catenin independent inhibition of mitotic spindle formation. Oncogene. 2011, 30: 2558-2569. 10.1038/onc.2010.627
    Article PubMed Central CAS PubMed Google Scholar
  100. Hirner H, Günes C, Bischof J, Wolff S, Grothey A, Kühl M, Oswald F, Wegwitz F, Bösl MR, Trauzold A, Henne-Bruns D, Peifer C, Leithäuser F, Deppert W, Knippschild U: Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo. PLoS One. 2012, 7: e29709- 10.1371/journal.pone.0029709
    Article PubMed Central CAS PubMed Google Scholar
  101. Sinnberg T, Menzel M, Ewerth D, Sauer B, Schwarz M, Schaller M, Garbe C, Schittek B: β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One. 2011, 6: e23429- 10.1371/journal.pone.0023429
    Article PubMed Central CAS PubMed Google Scholar
  102. Vaid M, Prasad R, Sun Q, Katiyar SK: Silymarin Targets ?-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells. PLoS One. 2011, 6: e23000- 10.1371/journal.pone.0023000
    Article PubMed Central CAS PubMed Google Scholar
  103. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT: Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A. 2009, 106: 1193-1198. 10.1073/pnas.0811902106
    Article PubMed Central CAS PubMed Google Scholar
  104. Lucero OM, Dawson DW, Moon RT, Chien AJ: A re-evaluation of the “oncogenic” nature of Wnt/beta-catenin signaling in melanoma and other cancers. Curr Oncol Rep. 2010, 12: 314-318. 10.1007/s11912-010-0114-3
    Article PubMed Central CAS PubMed Google Scholar
  105. Chien AJ, Haydu LE, Biechele TL, Kulikauskas RM, Rizos H, Kefford RF, Scolyer RA, Moon RT, Long GV: Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling. PLoS One. 2014, 9: e94748- 10.1371/journal.pone.0094748
    Article PubMed Central PubMed CAS Google Scholar
  106. Yu DH, Macdonald J, Liu G, Lee AS, Ly M, Davis T, Ke N, Zhou D, Wong Staal F, Li QX: Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy. PLoS One. 2008, 3: e3951- 10.1371/journal.pone.0003951
    Article PubMed Central PubMed CAS Google Scholar
  107. Deng L, Lei Y, Liu R, Li J, Yuan K, Li Y, Chen Y, Liu Y, Lu Y, Edwards CK, Huang C, Wei Y: Pyrvinium targets autophagy addiction to promote cancer cell death. Cell Death Dis. 2013, 4: e614- 10.1038/cddis.2013.142
    Article PubMed Central CAS PubMed Google Scholar
  108. Zou F-Y, Xie H-L, Chen Z-C, He C-M, Guan Y-J, Li YJ: [Effect of HLCDG1 gene transfection on growth of lung carcinoma cells]. Ai Zheng. 2003, 22: 1121-1126.
    CAS PubMed Google Scholar
  109. Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, Burstain I, Morgenstern Y, Brachya G, Billauer H, Biton S, Snir-Alkalay I, Vucic D, Schlereth K, Mernberger M, Stiewe T, Oren M, Alitalo K, Pikarsky E, Ben-Neriah Y: A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell. 2013, 24: 242-256. 10.1016/j.ccr.2013.06.005
    Article CAS PubMed Google Scholar
  110. Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, Frazier J, Chau BN, Loboda A, Linsley PS, Cleary MA, Park JR, Grandori C: Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci U S A. 2012, 109: 9545-9550. 10.1073/pnas.1121119109
    Article PubMed Central CAS PubMed Google Scholar
  111. Bibian M, Rahaim RJ, Choi JY, Noguchi Y, Schürer S, Chen W, Nakanishi S, Licht K, Rosenberg LH, Li L, Feng Y, Cameron MD, Duckett DR, Cleveland JL, Roush WR: Development of highly selective casein kinase 1δ/1ϵ (CK1δ/ϵ) inhibitors with potent antiproliferative properties. Bioorg Med Chem Lett. 2013, 23: 4374-4380. 10.1016/j.bmcl.2013.05.075
    Article PubMed Central CAS PubMed Google Scholar

Download references